Xenleta

Active Ingredient(s): Lefamulin Acetate
FDA Approved: * August 19, 2019
Pharm Company: * NABRIVA THERAPEUTICS US INC

Lefamulin, sold under the brand name Xenleta, is an antibiotic medication used it to treat adults with community-acquired bacterial pneumonia.[3][4] It is taken by mouth or by injection into a vein.[3][4][5] Relatively common side effects include diarrhea, nausea, pain at the site of injection, and liver inflammation.[3][6] It is a pleuromutilin antibiotic that inhibits the large su... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Xenleta 600 mg Oral Tablet, Coated
NDC: 72000-110
Labeler:
Nabriva Therapeutics Us, Inc.
Xenleta 150 mg/15ml Intravenous Injection, Solution
NDC: 72000-120
Labeler:
Nabriva Therapeutics Us, Inc.